Jul 31, 2018 7:30am EDT Avalon GloboCare Appoints Prominent Life Science M&A Attorney Steven Sanders to the Board of Directors
Jul 18, 2018 7:30am EDT Avalon GloboCare Announces Plans to Accelerate Commercialization of Proprietary CAR-T Technologies through Launch of Wholly Owned Subsidiary - Avactis Biosciences
Jul 10, 2018 7:30am EDT Avalon GloboCare Appoints Senior Healthcare Executive William Stilley to Board of Directors
Jun 12, 2018 7:30am EDT Avalon GloboCare Forms Joint Venture with Jiangsu Unicorn to Establish Provincial Network of Translational Cellular Therapy and Bio-Banking Programs
Jun 04, 2018 7:00am EDT Avalon GloboCare Appoints Former Deputy Secretary of the U.S. Department of Health and Human Services Dr. Tevi Troy to its Board of Directors
May 14, 2018 8:00am EDT Avalon GloboCare Provides First Quarter 2018 Business Update; Reports 365% Increase in Revenues and Progress Towards Commercialization of its Cell-Based Technologies
Apr 24, 2018 7:30am EDT Avalon GloboCare Forms Joint Laboratory with Top-Ranked Hospital in Shanghai for Regenerative Exosomics
Feb 28, 2018 7:30am EST Avalon GloboCare Teams up with Weill Cornell Medicine to Establish Joint Translational Research Initiative in Stem Cell Technology and Regenerative Medicine